[Intravenous lidocaine as treatment for the painful episodes in Fabry's disease].
Politei
J M
JM
D000328:Adult; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D003251:Constriction, Pathologic; D000795:Fabry Disease / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D005260:Female; D006579:Heterozygote; D006801:Humans; D007262:Infusions, Intravenous; D007511:Ischemia / Q000209:etiology; D007527:Isoenzymes / Q000627:therapeutic use; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D020125:Mutation, Missense; D009412:Nerve Fibers / Q000187:drug effects / Q000502:physiology; D009437:Neuralgia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D010525:Peripheral Nerves / Q000098:blood supply / Q000187:drug effects / Q000503:physiopathology; D017354:Point Mutation; D015222:Sodium Channels / Q000187:drug effects / Q000502:physiology; D014650:Vasa Nervorum / Q000473:pathology; D055815:Young Adult; D000519:alpha-Galactosidase / Q000235:genetics / Q000627:therapeutic use
D000779:Anesthetics, Local; D007527:Isoenzymes; D015222:Sodium Channels; D008012:Lidocaine; D000519:alpha-Galactosidase; C459420:agalsidase beta